AstraZeneca vaccine 79% effective in US trial, panel finds no higher risk of clots
AstraZeneca and Oxford University's COVID-19 vaccine was 79% effective in a large US trial at preventing symptomatic illness, and was 100% effective against severe or critical disease and hospitalisation, the drugmaker said on Monday.
from bdnews24.com - Home https://ift.tt/3lBgIVK
from bdnews24.com - Home https://ift.tt/3lBgIVK
No comments